glp-1 agonist drugs Receptor Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1 receptor agonists – How
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 141.Hooper L, Liu S, Pai MP

Abstract Despite an ever-growing prevalence and increasing economic burden of Alzheimers disease (AD) and Parkinsons disease (PD), recent advances in drug development have only resulted in minimally effective treatment

Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome

[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Li L., Shen J., Bala M.M., Busse J.W., Ebrahim S., Vandvik P.O., Rios L.P., Malaga G., Wong E., Sohani Z., et al

We see no signals

10.1111/jne.12643 5 GierB.MatveyenkoA
